BAYRY
Price
$5.87
Change
+$0.04 (+0.69%)
Updated
Apr 3 closing price
Capitalization
57.55B
39 days until earnings call
BIIB
Price
$128.02
Change
-$2.69 (-2.06%)
Updated
Apr 4, 10:45 AM (EDT)
Capitalization
31.34B
27 days until earnings call
Ad is loading...

BAYRY vs BIIB

Header iconBAYRY vs BIIB Comparison
Open Charts BAYRY vs BIIBBanner chart's image
Bayer A.G
Price$5.87
Change+$0.04 (+0.69%)
Volume$615.05K
Capitalization57.55B
Biogen
Price$128.02
Change-$2.69 (-2.06%)
Volume$1.05K
Capitalization31.34B
BAYRY vs BIIB Comparison Chart
Loading...
BAYRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BIIB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BAYRY vs. BIIB commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BAYRY is a Hold and BIIB is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (BAYRY: $5.87 vs. BIIB: $130.71)
Brand notoriety: BAYRY: Not notable vs. BIIB: Notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: BAYRY: 85% vs. BIIB: 104%
Market capitalization -- BAYRY: $57.55B vs. BIIB: $31.34B
BAYRY [@Pharmaceuticals: Major] is valued at $57.55B. BIIB’s [@Pharmaceuticals: Major] market capitalization is $31.34B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BAYRY’s FA Score shows that 0 FA rating(s) are green whileBIIB’s FA Score has 0 green FA rating(s).

  • BAYRY’s FA Score: 0 green, 5 red.
  • BIIB’s FA Score: 0 green, 5 red.
According to our system of comparison, BAYRY is a better buy in the long-term than BIIB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BAYRY’s TA Score shows that 4 TA indicator(s) are bullish while BIIB’s TA Score has 5 bullish TA indicator(s).

  • BAYRY’s TA Score: 4 bullish, 5 bearish.
  • BIIB’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, BIIB is a better buy in the short-term than BAYRY.

Price Growth

BAYRY (@Pharmaceuticals: Major) experienced а -4.40% price change this week, while BIIB (@Pharmaceuticals: Major) price change was -6.86% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -1.76%. For the same industry, the average monthly price growth was -3.23%, and the average quarterly price growth was -8.15%.

Reported Earning Dates

BAYRY is expected to report earnings on May 13, 2025.

BIIB is expected to report earnings on May 01, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-1.76% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BAYRY($57.5B) has a higher market cap than BIIB($31.3B). BIIB has higher P/E ratio than BAYRY: BIIB (26.95) vs BAYRY (17.04). BAYRY YTD gains are higher at: 20.287 vs. BIIB (-14.524). BAYRY has higher annual earnings (EBITDA): 12.1B vs. BIIB (2.04B). BAYRY has more cash in the bank: 7.98B vs. BIIB (1.05B). BAYRY has higher revenues than BIIB: BAYRY (50.5B) vs BIIB (9.84B).
BAYRYBIIBBAYRY / BIIB
Capitalization57.5B31.3B184%
EBITDA12.1B2.04B594%
Gain YTD20.287-14.524-140%
P/E Ratio17.0426.9563%
Revenue50.5B9.84B513%
Total Cash7.98B1.05B760%
Total DebtN/A7.34B-
FUNDAMENTALS RATINGS
BAYRY vs BIIB: Fundamental Ratings
BAYRY
BIIB
OUTLOOK RATING
1..100
7757
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
94
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9267
PRICE GROWTH RATING
1..100
6064
P/E GROWTH RATING
1..100
8496
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BAYRY's Valuation (66) in the null industry is in the same range as BIIB (94) in the Biotechnology industry. This means that BAYRY’s stock grew similarly to BIIB’s over the last 12 months.

BAYRY's Profit vs Risk Rating (100) in the null industry is in the same range as BIIB (100) in the Biotechnology industry. This means that BAYRY’s stock grew similarly to BIIB’s over the last 12 months.

BIIB's SMR Rating (67) in the Biotechnology industry is in the same range as BAYRY (92) in the null industry. This means that BIIB’s stock grew similarly to BAYRY’s over the last 12 months.

BAYRY's Price Growth Rating (60) in the null industry is in the same range as BIIB (64) in the Biotechnology industry. This means that BAYRY’s stock grew similarly to BIIB’s over the last 12 months.

BAYRY's P/E Growth Rating (84) in the null industry is in the same range as BIIB (96) in the Biotechnology industry. This means that BAYRY’s stock grew similarly to BIIB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BAYRYBIIB
RSI
ODDS (%)
Bearish Trend 1 day ago
72%
Bullish Trend 1 day ago
69%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
51%
Bullish Trend 1 day ago
50%
Momentum
ODDS (%)
Bearish Trend 1 day ago
61%
Bearish Trend 1 day ago
68%
MACD
ODDS (%)
Bearish Trend 1 day ago
67%
Bearish Trend 1 day ago
75%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
69%
Bearish Trend 1 day ago
70%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
65%
Bearish Trend 1 day ago
70%
Advances
ODDS (%)
Bullish Trend 8 days ago
59%
Bullish Trend 26 days ago
53%
Declines
ODDS (%)
Bearish Trend 12 days ago
70%
Bearish Trend 1 day ago
69%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
47%
Bullish Trend 1 day ago
69%
Aroon
ODDS (%)
Bullish Trend 1 day ago
47%
Bullish Trend 1 day ago
34%
View a ticker or compare two or three
Ad is loading...
BAYRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BIIB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ICFI83.99-2.28
-2.64%
ICF International
MNTS1.88-0.09
-4.57%
Momentus Inc
STIM3.60-0.34
-8.63%
Neuronetics
FOX47.90-5.10
-9.62%
Fox Corp
PRAX33.30-3.81
-10.27%
Praxis Precision Medicines

BAYRY and

Correlation & Price change

A.I.dvisor indicates that over the last year, BAYRY has been closely correlated with BAYZF. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if BAYRY jumps, then BAYZF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BAYRY
1D Price
Change %
BAYRY100%
+0.69%
BAYZF - BAYRY
88%
Closely correlated
+2.29%
OPHLY - BAYRY
23%
Poorly correlated
+0.58%
SNY - BAYRY
23%
Poorly correlated
+1.24%
AZN - BAYRY
21%
Poorly correlated
+2.35%
BIIB - BAYRY
20%
Poorly correlated
-0.46%
More